Brunde E. Broady - Dec 15, 2022 Form 4 Insider Report for NATURAL HEALTH TRENDS CORP (NHTC)

Role
Director
Signature
/s/ Timothy S. Davidson, by Power of Attorney
Stock symbol
NHTC
Transactions as of
Dec 15, 2022
Transactions value $
-$4,673
Form type
4
Date filed
12/16/2022, 08:02 AM
Previous filing
Sep 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHTC Common Stock Options Exercise +1.3K 1.3K Dec 15, 2022 Direct F1
transaction NHTC Common Stock Disposed to Issuer -$4.67K -1.3K -100% $3.60 0 Dec 15, 2022 Direct
holding NHTC Common Stock 0 Dec 15, 2022 See Footnotes F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHTC Phantom Stock Options Exercise -1.3K -100% 0 Dec 15, 2022 Common Stock 1.3K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each phantom share entities the holder to receive a cash payment equal to the fair market value of one share of NHTC common stock on the applicable vesting date, subject to satisfaction of the applicable vesting conditions and a maximum payment value of $12.00 per phantom share.
F2 Ms. Broady is co-trustee of the Eleanor Jane Broady 2012 Irrevocable Trust (the "EJB Trust") along with four other co-trustees, and the co-trustees must act jointly through a majority in order to take action under the terms of the EJB Trust, including the exercise of voting or investment powers with respect to the 2,245,128 shares of common stock of Natural Health Trends Corp. (the "Company") held by the EJB Trust. Ms. Broady expressly disclaims beneficial ownership of any shares of the Company's common stock held by the EJB Trust, within the meaning of Rule 13d-3 under the Securities Act of 1934.
F3 Ms. Broady, along with four other individuals is currently named a successor co-trustee of the George K. Broady 2012 Irrevocable Trust (the "GKB Trust"), and that in the event such successor co-trustees commencing serving as co-trustees, they must act jointly through a majority in order to take action under the terms of the GKB Trust, including the exercise of voting or investment powers with respect to the 690,099 shares of the Company's common stock held by the GKB Trust. Ms. Broady expressly disclaims beneficial ownership of any shares of the Company's common stock held by the GKB Trust, within the meaning of Rule 13d-3 under the Securities Act of 1934.
F4 No derivative securities are beneficially owned following the reported transaction.